1. Home
  2. IPHA vs TBRG Comparison

IPHA vs TBRG Comparison

Compare IPHA & TBRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IPHA
  • TBRG
  • Stock Information
  • Founded
  • IPHA 1999
  • TBRG 1979
  • Country
  • IPHA France
  • TBRG United States
  • Employees
  • IPHA N/A
  • TBRG N/A
  • Industry
  • IPHA Biotechnology: Pharmaceutical Preparations
  • TBRG
  • Sector
  • IPHA Health Care
  • TBRG
  • Exchange
  • IPHA Nasdaq
  • TBRG NYSE
  • Market Cap
  • IPHA 191.0M
  • TBRG 186.6M
  • IPO Year
  • IPHA 2019
  • TBRG N/A
  • Fundamental
  • Price
  • IPHA $2.23
  • TBRG $12.59
  • Analyst Decision
  • IPHA Strong Buy
  • TBRG Buy
  • Analyst Count
  • IPHA 1
  • TBRG 2
  • Target Price
  • IPHA $11.50
  • TBRG $13.50
  • AVG Volume (30 Days)
  • IPHA 6.6K
  • TBRG 51.6K
  • Earning Date
  • IPHA 09-12-2024
  • TBRG 11-06-2024
  • Dividend Yield
  • IPHA N/A
  • TBRG N/A
  • EPS Growth
  • IPHA N/A
  • TBRG N/A
  • EPS
  • IPHA N/A
  • TBRG N/A
  • Revenue
  • IPHA $36,202,722.00
  • TBRG $336,557,000.00
  • Revenue This Year
  • IPHA N/A
  • TBRG $0.94
  • Revenue Next Year
  • IPHA $105.84
  • TBRG $4.58
  • P/E Ratio
  • IPHA N/A
  • TBRG N/A
  • Revenue Growth
  • IPHA N/A
  • TBRG N/A
  • 52 Week Low
  • IPHA $1.81
  • TBRG $7.55
  • 52 Week High
  • IPHA $3.15
  • TBRG $17.28
  • Technical
  • Relative Strength Index (RSI)
  • IPHA 44.65
  • TBRG 52.41
  • Support Level
  • IPHA $2.22
  • TBRG $11.68
  • Resistance Level
  • IPHA $2.35
  • TBRG $12.45
  • Average True Range (ATR)
  • IPHA 0.13
  • TBRG 0.41
  • MACD
  • IPHA -0.01
  • TBRG -0.06
  • Stochastic Oscillator
  • IPHA 20.59
  • TBRG 46.12

About IPHA Innate Pharma S.A. ADS

Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.

About TBRG TRUBRIDGE INC

TruBridge Inc is a provider of healthcare solutions and services for community hospitals, clinics, and other healthcare systems. It provides services such as Electronic health records & information systems, revenue cycle management, population health, and data management, etc. The segments of the company are RCM, EHR, and Patient Engagement. The company derives maximum revenue from the RCM segment.

Share on Social Networks: